No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ALT Altimmune
- 5.910
- -0.010-0.17%
Close Jun 18 16:00 ET
- 5.860
- -0.050-0.85%
Post 19:22 ET
419.03MMarket Cap-3693P/E (TTM)
5.930High5.640Low3.50MVolume5.930Open5.920Pre Close20.20MTurnover4.97%Turnover RatioLossP/E (Static)70.90MShares14.84052wk High2.42P/B415.72MFloat Cap2.09052wk Low--Dividend TTM70.34MShs Float978.000Historical High--Div YieldTTM4.90%Amplitude-1731.000Historical Low5.779Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Altimmune Announces Oral Presentations of Pemvidutide Clinical Data at Upcoming American Diabetes Association’s Scientific Sessions
New Weight-Loss Drugs and Devices Are Coming This Week -- Barrons.com
The weight-loss breakthroughs now dominating headlines all emerged from diabetes treatment.
USA faces the most severe drug shortage in a decade, with low stock price drugs and weight loss drugs becoming "disaster zones".
Last year, the USA experienced the most serious drug shortage crisis in a decade.
JPMorgan to Wager on Weight-Loss Craze With $500 Million Fund
JPMorgan Chase & Co.’s asset-management arm raised more than $500 million for a biotech venture-capital fund that will bet on the hottest corner of health care: weight-loss drugs
GLP-1 Obesity Drug Coverage Dropped by Blue Cross Michigan: Report
Express News | Altimmune Presents Data at Easl International Liver Congress™ 2024 Supporting the Disease Modifying Potential and Differentiated Therapeutic Profile of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis (Mash)
Comments
$Altimmune(ALT.US$ DEATH CROSS
$Altimmune(ALT.US$ wake up dipshit
$Altimmune (ALT.US)$ here we go let's get it back up again peeps
2
I jumped onto ALT stock and made $Altimmune (ALT.US)$ and made $92 profit that day. I do not have my spread sheet now to give the buy and sell price. I could have slapped myself for exiting too early. I am trading too many stocks at once which reduces my ability to focus well on a chart. working on eliminating that. My goal is to have 2-3 long term investment and swing only 1 at a time. I'm still a novice but improving
1
8
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
